Medline legal chief Alexander M. Liberman exchanges units
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Medline Inc. (MDLN) Chief Legal Officer Alexander M. Liberman reported an exchange of Medline Holdings, LP Incentive Units for Common Units on November 12, 2026. The four reported Incentive Unit amounts and per-unit participation thresholds were 1,129,447 at $15.09, 85,102 at $14.90, 42,080 at $18.68 and 14,449 at $27.35; the units were held indirectly through Medline Management Aggregator LLC. Common Units are exchangeable one-for-one for Class A common shares.
In connection with the exchange, Common Units reported as delivered or withheld for payment of exercise price or tax liability were 413,038 at $26.67 per share, 30,815 at $26.82, 19,027 at $23.04 and 9,518 at $14.35. The exchange also automatically issued Class B shares in four reported amounts: 716,409, 54,287, 23,053 and 4,931. A trust for which Liberman’s spouse is trustee held 234,177 Common Units and 234,177 Class B shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Units of Medline Holdings, LP F1, F2, F3 | 1,129,447 | -- | -- |
| Exercise | Incentive Units of Medline Holdings, LP F1, F2, F4 | 85,102 | -- | -- |
| Exercise | Incentive Units of Medline Holdings, LP F1, F2, F5 | 42,080 | -- | -- |
| Exercise | Incentive Units of Medline Holdings, LP F1, F2, F6 | 14,449 | -- | -- |
| Exercise | Common Units of Medline Holdings, LP F8, F1, F2 | 1,129,447 | -- | -- |
| Exercise | Common Units of Medline Holdings, LP F8, F1, F2 | 85,102 | -- | -- |
| Exercise | Common Units of Medline Holdings, LP F8, F1, F2 | 42,080 | -- | -- |
| Exercise | Common Units of Medline Holdings, LP F8, F1, F2 | 14,449 | -- | -- |
| Exercise Price or Tax Liability | Common Units of Medline Holdings, LP F8, F10, F1, F2 | 413,038 | $26.67 | $11.02M |
| Exercise Price or Tax Liability | Common Units of Medline Holdings, LP F8, F10, F1, F2 | 30,815 | $26.82 | $826K |
| Exercise Price or Tax Liability | Common Units of Medline Holdings, LP F8, F10, F1, F2 | 19,027 | $23.04 | $438K |
| Exercise Price or Tax Liability | Common Units of Medline Holdings, LP F8, F10, F1, F2 | 9,518 | $14.35 | $137K |
| Grant/Award | Class B Common Stock F1, F2, F9 | 716,409 | -- | -- |
| Grant/Award | Class B Common Stock F1, F2, F9 | 54,287 | -- | -- |
| Grant/Award | Class B Common Stock F1, F2, F9 | 23,053 | -- | -- |
| Grant/Award | Class B Common Stock F1, F2, F9 | 4,931 | -- | -- |
| Holding | Common Units of Medline Holdings, LP F8, F7 | -- | -- | -- |
| Holding | Class B Common Stock F7 | -- | -- | -- |
Footnotes (10)
- F1. Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
- F2. (Continued from Footnote 1 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. In connection with the conversion of Incentive Units into Common Units, upon issuance of Common Units, an equivalent number of shares of Class B common stock ("Class B Common Stock") are automatically issued.
- F3. These Incentive Units are fully vested.
- F4. 60% of these Incentive Units have vested, and the remaining 40% vest in two equal annual installments beginning on April 1, 2027.
- F5. 40% of these Incentive Units have vested, and the remaining 60% vest in three equal annual installments beginning on March 29, 2027.
- F6. 20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on March 28, 2027.
- F7. These securities are held by a trust, of which the Reporting Person's spouse is the trustee.
- F8. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC.
- F9. Shares of the Issuer's Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock are automatically cancelled.
- F10. Reflects Common Units deemed to be withheld in connection with the exchange of Incentive Units described herein.
Key Figures
Key Terms
Incentive Units financial
profit interests financial
participation threshold financial
Exchange Agreement financial
Common Units financial
Class B Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Medline (MDLN) Chief Legal Officer Alexander M. Liberman report?
What vesting terms applied to the Medline Incentive Units?
AI-generated analysis. How Rhea-AI works. Not financial advice.